Cancer Related News
A new trial on proton beam therapy will be carried out in the UK
A new trial testing the benefits of proton beam therapy for breast cancer patients will go ahead for the first time in the UK.
The...
AI is being used to detect colon cancer in Lynch syndrome patients
Artificial Intelligence (AI) is now being used to check for colorectal cancer in people with Lynch syndrome, who are more likely to have a...
The University of Glasgow to receive £1.7m funding to explore the causes of cancer
Scientists are set to receive £1.7 million from Cancer Research UK to investigate the root causes of cancer and how to improve treatments.
Cancer is...
Understanding how epigenetics can improve cancer treatment
Researchers from the University of Barcelona have explained the role epigenetics can play in clinical cancer treatment.
In the early 1980s, methylation was discovered and...
NICE has recommended the anti-cancer drug Enhertu for earlier use
Hundreds more people are now eligible for the breast cancer drug Enhertu as NICE recommends for use in the disease’s early stages
This means NICE...
Defence’s novel Accutox intranasal reduces 50% of cancer nodules
Defence Therapeutics, a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, has just completed a pre-clinical study using...
One in five GPs unwilling to prescribe aspirin to Lynch syndrome patients
New data finds that one in five GPs could be unwilling to prescribe aspirin to patients with Lynch syndrome, a cancer-causing condition.
A study carried...
Researchers identify origins of Langerhans cell histiocytosis in children
The origins of Langerhans cell histiocytosis have been identified by researchers from Karolinska Institutet in collaboration with Karolinska University Hospital.
Langerhans cell histiocytosis is a...
Defence Therapeutics are using Accum technology in mRNA vaccines
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is currently working on combining its...
New mRNA cancer vaccine significantly reduces disease
An mRNA cancer vaccine, developed by Moderna and Merck, demonstrated a statistically significant and clinically meaningful reduction in risk of disease recurrence or death.
The...
CAR T Cell therapy used to treat leukaemia for the first time
In a world first, a patient with relapsed T cell leukaemia has received base-edited CAR T cell therapy at Great Ormond Street Hospital.
In 2021,...
WHO launch health literacy initiatives for migrant communities
The National School of Public Health in Portugal have worked alongside the World Health Organization (WHO) to develop new health literacy initiatives for migrant...
Researchers identify three new subtypes of brain cancer
Three new subtypes of brain cancer have been discovered by researchers from RCSI University of Medicine and Health Sciences in Dublin.
The new subtypes of...
Defence Therapeutics to begin phase 1 trial for new anti-cancer treatment
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the successful...
OmniSpirant Limited launch new gene therapy treatment project
INSPIRE is an EU Project funded under the Horizon Europe research and innovation programme to develop a ground-breaking inhaled gene therapy treatment for lung...
NHS fast-tracks life-extending prostate cancer treatment
A life-extending prostate cancer treatment will be available on the NHS, benefitting around 9,000 men.
The NHS in England will become the first healthcare system...
High-precision medicine can improve treatment for ovarian cancer
An international team of researchers have found that high-precision medicines can be used in oncology, allowing for better treatment for ovarian cancer.
Mutations of BRCA1...
More ethnic diversity is needed in genomic cancer data
Two recent studies have highlighted the need for greater ethnic diversity in genomic prostate cancer data and accessible genetic testing.
Over 1.4 million men were...
New life-extending treatment recommended for rare gastroesophageal cancer
Around 3,000 people could be eligible for a new life-extending combination therapy to treat rare forms of gastroesophageal cancer.
Gastroesophageal cancer, also known as gastroesophageal...
Defence’s successful study on the ACCUVAC-PT007 vaccine
Defence Therapeutics Inc. has announced its successful study on its ACCUVAC-PT007 vaccine, which targets cervical cancer.
Defence Therapeutics Inc. a Canadian biopharmaceutical company specialised in...
